Conduction velocity (CV) 
Introduction
Several cardiac diseases exhibit dispersion of electrical conduction velocity (CV), including atrial fibrillation [1] , Brugada Syndrome [2] , hypertrophic cardiomyopathy [3] and arrhythmogenic right ventricular cardiomyopathy (ARVC) [4] . Slow and heterogeneous CV, in combination with appropriate anatomical substrates, translates into an increased risk of re-entry. Even in the absence of structural heart changes, such as in early-stage ARVC patients with ion channel remodelling but otherwise healthy hearts [4] , CV abnormalities have been shown to cause sudden cardiac death in young individuals [5] .
Cardiac voltage-gated sodium channels (INa) are transmembrane proteins responsible for regulating the flow of sodium ions. Loss-of-function mutations in INa channels have been implicated in lethal arrhythmias [6] . The inward rectifier current (IK1) stabilises the resting membrane potential of the human action potential (AP). IK1 downregulation has been also experimentally linked to the creation of regional differences in cardiac excitability [7] .
Emerging experimental evidence suggests that ionic channels are not regulated independently and are organised in macromolecular complexes. The INa-IK1 ion channels form one such complex, recently shown to control cardiac excitability and arrhythmia by Milstein et al. [8] . Their inter-species study concluded that an increase in functional expression of one channel reciprocally modulates the expression of the other to maximise cardiac excitability.
The This study extends to human electrophysiology the in silico study by Varghese [10] , where CV modulation by the INa-IK1 complex was investigated using a mammalian model. Importantly, we focus on INa-IK1 downregulation rather than its overexpression, given the reported role of reduced function of these channels in arrhythmogenesis. We further investigate rate-dependence interactions of the INa-IK1 complex on human ventricular CV, as well as its modulation by [K + ]o plasma levels.
Methods

Human tissue electrophysiology model
At the cellular level, this study was conducted using the O'Hara-Rudy (ORd) model, as state-of-the-art and most extensively validated human cardiac electrophysiology model [11] , which incorporates all main ionic channels and subcellular processes involved in the human AP.
Tissue simulations using the bidomain equations were performed in 1D fibres (2 cm length; spatial discretisation 0.4 mm; ODE and PDE time steps of 0.025 and 0.05 ms, respectively), ensuring numerical convergence of our solver [12] . Tissue conductivities were selected as described in [13] for human transmural propagation.
Simulation protocols
The 5 leftmost nodes of the fibres were simultaneously stimulated using square waves (1 ms duration; 120 pA/pF amplitude), and fibres were paced until steady-state before CV recordings took place. Activation times (ms) were determined at the steepest upstroke of the AP at each node. The CV was subsequently calculated by a least squares linear estimate of the resulting activation curves.
To investigate the effects of INa-IK1 downregulation on human ventricular CV, simulations were conducted via a parameter sweep for these two channels using scaling factors in the [0. 
Results
Low frequency pacing limit
At low pacing rates equivalent to sinus rhythm (BCL > 600 ms), human ventricular CV was found to be almost entirely controlled by the INa conductance. When decreasing INa maximal channel density (smaller GNa scaling factors), the CV also monotonically decreases, as illustrated in Figure 1a . On the other hand, CV varies by less than 1% within the range of GK1 scaling factors studied, implying a weak dependence of CV on IK1 in this low frequency pacing limit.
High frequency pacing limit
The high frequency pacing range is not reachable in sinus rhythm and is presented here to simulate arrhythmic scenarios. At fast pacing frequencies (BCL ≤ 300 ms), the CV was found to be dependent on INa-IK1 interactions. The CV exhibited a positive correlation with both GNa and GK1 scaling factors (Fig 1b) . Such a phenomenon only emerges at fast pacing BCLs, mimicking arrhythmic conditions. This suggests that once arrhythmias are initiated, the upper limit of CV of electrical wavefronts will depend on subject-specific INa-IK1 ionic channel balance. ]o implies an increased maximal IK1 repolarising current, and hence a shortening of the AP. The same holds for the fast delayed repolarising potassium current IKr.
Hyperkalemia reduces human CV
Simulation results confirm these mechanisms, as shown in Fig 2. Hence, INa peak availability is severely reduced and CV rapidly decreases under hyperkalemic conditions for all the studied combinations of the INa-IK1 complex, as captured by Fig 3 in the high frequency pacing limit (BCL of 300 ms). The same behavior was observed for the slow frequency pacing limit (BCL > 600 ms, not shown). 
3.4
Biphasic hypokalemic response of CV Interestingly, our simulation results indicate a biphasic response of human CV to low [K + ]o (Fig 3) . For mild hypokalemia, CV increases due to a larger INa availability. However, at very low [K + ]o values, the markedly lower resting membrane potential outweighs this speed up, ultimately yielding a slower CV for severe hypokalemia.
CV can be increased due to an increased INa availability via an enhanced recovery from inactivation. The low [K + ]o increases the diffusion gradient across the cell membrane, resulting in a hyperpolarization of the resting membrane potential (Fig 4a) . Contrary to hyperkalemia, hypokalemia opens the voltage-dependent INa inactivation gates, once the cell has recovered (Fig 4b) . In addition, the lower [K + ]o availability directly reduces the maximal densities of IK1 and IKr currents (Fig 4c) . This, in combination with a more prominent AP upstroke and the more negative resting membrane potential, increases the repolarisation time of the ventricular myocyte, leading to a prolonged AP as experimentally confirmed in hypokalemia [14] .
On the other hand, a lower resting potential implies that electrotonic currents must increase the transmembrane potential by a larger voltage difference before the INa channel is triggered in a neighboring myocyte. Hence, this slows the electrical propagation and decreases CV [14] . The same behavior was observed for the slow frequency pacing limit (BCL > 600 ms, not shown). 
Hypokalemia abolishes IK1 role on CV
Finally, INa-IK1 complex modulation of human CV under hypo/hyperkalemic conditions was also investigated. CV under hyperkalemia did not qualitatively change the previously described influence of the INa-IK1 complex on CV in control [K + ]o levels (sections 3.1 and 3.2). On the contrary, the CV dependence on IK1 was almost completely abolished under hypokalemia (Fig 5) . This is a result of the reduced maximal IK1 density for low
Conclusions
In this study we have conducted a thorough in silico investigation of the impact of ion channel downregulation in the INa-IK1 complex on human ventricular CV, as well as its rate dependence and modulation by [K + ]o plasma levels. Our results suggest that a positive correlation between IK1 conductance and human ventricular CV is only present at fast pacing regimes, representative of arrhythmic scenarios (BCL ≤ 300 ms). At slower BCLs, CV was found to be solely governed by the INa channel conductance. An important novel finding is the biphasic response of human CV under hypokalemic conditions. An increase in CV is observed for mild hypokalemia due to increased INa availability, counteracted at severe episodes by the effect of a markedly hyperpolarised resting membrane potential on electrotonic currents, independent of INa-IK1 conductances. A final finding is that the IK1 dependence of CV is abolished during severe hypokalemia, due to reduced maximal IK1 density for low [K + ]o. These findings may therefore have important implications in promoting our current understanding of INa-IK1 modulation of dispersion of electrical conduction under heart disease.
